Pricing Log in Create free account

Replimune Group, Inc. (REPL) vs Vera Therapeutics, Inc. (VERA)

Replimune Group, Inc. and Vera Therapeutics, Inc. are both Biotechnology companies. Replimune Group, Inc. and Vera Therapeutics, Inc. are of similar size ($2.2B and $2.2B). Across the 10 metrics below, Replimune Group, Inc. leads on 5 and Vera Therapeutics, Inc. on 5.

Valuation

Metric REPL VERA Biotechnology median
P/E n/m n/m 11.58
P/S n/m n/m 9.61
P/B 11.24 5.34 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales n/m n/m 9.43
Earnings yield (12.77%) (19.33%) (32.28%)
Free cash flow yield (10.68%) (15.56%) (22.27%)

Profitability

Metric REPL VERA Biotechnology median
Gross margin 0.00% 0.00% 68.81%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (115.80%) (91.75%) (50.30%)
Return on assets (71.01%) (72.32%) (45.47%)
Return on invested capital (928.27%) 0.00% 0.00%

Growth

Metric REPL VERA Biotechnology median
Revenue growth (TTM) — — 6.78%
EPS growth (last fiscal year) (10.10%) (69.45%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric REPL VERA Biotechnology median
Debt to equity 0.59 0.18 0.00
Current ratio 7.11 10.92 4.74
Net debt to EBITDA 0.51 2.00 1.01

Dividend

Metric REPL VERA Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric REPL VERA Biotechnology median
Market cap 2.21b 2.17b 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack